Literature DB >> 10388523

A src-related kinase in the brush border membranes of gastrointestinal cells is regulated by c-met.

I Sunitha1, R Shen, I H McKillop, J H Lee, J Resau, M Avigan.   

Abstract

Hepatocyte growth factor (HGF) elicits pleiotropic cellular responses by binding to c-met, a PTK transmembrane receptor. The recent identification of HGF in fluids which enter the gut lumen suggests a mechanism by which c-met molecules are accessible to ligand that is present near the apical surfaces of polarized enterocytes. A subset of c-met molecules was detected, by confocal and immunoelectron microscopic analysis, which colocalizes with a recently identified src-related gastrointestinal tyrosine kinase (gtk) in the brush border membranes of enterocytes. Furthermore, treatment of c-met/gtk-transfected cells with a chemical cross-linking agent revealed that c-met forms a physical complex with gtk, in vivo. Not surprisingly, activation of the receptor molecules with HGF rapidly stimulated gtk enzymatic activity. Similarly, the stimulation of gtk activity occurred when nontransfected primary hepatocytes were exposed to ligand. These findings suggest a model in which HGF binding to luminally accessible c-met stimulates gtk activity. This brush border-associated c-met-linked pathway may be associated with a defined set of epithelial cell responses. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10388523     DOI: 10.1006/excr.1999.4550

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

1.  Characterization of mice deficient in the Src family nonreceptor tyrosine kinase Frk/rak.

Authors:  Subhashini Chandrasekharan; Ting Hu Qiu; Nawal Alkharouf; Kelly Brantley; James B Mitchell; Edison T Liu
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 2.  RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK.

Authors:  Patrick M Brauer; Angela L Tyner
Journal:  Cell Cycle       Date:  2009-09-29       Impact factor: 4.534

Review 3.  Novel therapies for the management of short bowel syndrome in children.

Authors:  Marshall Z Schwartz
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

4.  PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine.

Authors:  M Buyse; F Berlioz; S Guilmeau; A Tsocas; T Voisin; G Péranzi; D Merlin; M Laburthe; M J Lewin; C Rozé; A Bado
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.